Market Snapshot: Flow Diversion Sees Highest Growth Among Neurointerventional Embolization Systems
Our infographic spotlights key trends in the global market for cerebral aneurysm and arteriovenous malformation (AVM) embolization systems, which is expected to reach $1.2bn by 2022, a CAGR of 3.9% from $975m in 2017. Among the growth drivers is the improvement of imaging screening techniques in developed nations. While this has resulted in increased intervention for cerebral aneurysm and AVM embolization, routine screening is not practiced, even in developed nations. Embolic coils accounted for the majority of sales with an estimated 73% market share. Meanwhile, a growing number of improved and premium-priced products such coil-assisted stent products and advanced embolic coil designs and flow diversion products are driving up the total value of the market.